We are live on ! Find out more

18 hedge funds and large institutions have $2.03M invested in Imunon in 2019 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

306% more call options, than puts

Call options by funds: $219K | Put options by funds: $54K

0% more funds holding

Funds holding: 1818 (0)

0% more ownership

Funds ownership: 0.03%0.03% (+0%)

0% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 4

6% less capital invested

Capital invested by funds: $2.15M → $2.03M (-$126K)

25% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 4

Holders
18
Holders Change
Holders Change %
0%
% of All Funds
0.39%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
3
Reduced
4
Closed
4
Calls
$219K
Puts
$54K
Net Calls
+$165K
Net Calls Change
+$154K

IMNN Hedge Fund Activity: Q3 2019 in Review

18 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Imunon (IMNN) for Q3 2019, worth a combined $2.03M — down 5.8% from $2.15M a quarter earlier.

Fund positioning in IMNN was balanced in Q3 2019: 4 funds opened new positions, 4 closed out, 3 added to existing stakes and 4 trimmed.

The largest buyer was Sabby Management, adding an estimated $219K. The largest seller was Virtu Financial, exiting entirely with an estimated $80K sold.

  • 18 institutional investors held Imunon (IMNN) as of Q3 2019, unchanged from Q2 2019.
  • Funds reported $2.03M of Imunon stock for Q3 2019, down 5.8% quarter-over-quarter.
  • 4 funds opened new Imunon positions in Q3 2019 and 4 closed out, a net change of 0 holders.
  • The largest Imunon buyer in Q3 2019 was Sabby Management, an estimated $219K added.
  • The largest Imunon seller in Q3 2019 was Virtu Financial, an estimated $80K sold.

Based on aggregated 13F filings for Q3 2019.